Richita Saikia

Dr. Richita Saikia

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2025 in Plants
Verified
Journal Article
Open access
PDF file
RSRichita Saikia
Richita Saikia
AKAthanasios Kaldis
Athanasios Kaldis
CSCarl Spetz
Carl Spetz
BBBasanta Kumar Borah
Basanta Kumar Borah
AVAndreas Voloudakis
Andreas Voloudakis
Plant viruses utilize a subset of host plasmodesmata-associated proteins to establish infection in plants. In the present study, we aimed to understand the role of two plant genes, one encoding a putative plasmodesma located protein (PDLP) and a homolog of soybean gene regulated by cold 2 protein (SRC2) during Cucumber mosaic virus (CMV) infection. Virus-induced gene silencing (VIGS) was used to silence PDLP and SRC2 genes in Nicotiana benthamiana and in two related solanaceous plants, N. tabacum and Capsicum chinense Jacq. (Bhut Jolokia). Up to 50% downregulation in the expression of the PDLP gene using the TRV2-PDLP VIGS construct was observed in N. benthamiana and N. tabacum while, using the same gene construct, 30% downregulation of the target mRNA was observed in C. chinense. Similarly, using the TRV2-SRC2 VIGS construct, a 60% downregulation of the SRC2 mRNA was observed in N. benthamiana, N. tabacum, and a 40% downregulation in C. chinense as confirmed by qRT-PCR analysis. Downregulation of the PDLP gene in N. benthamiana resulted in delayed symptom appearance up to 7–12 days post inoculation with reduced CMV accumulation compared to the control plants expressing TRV2-eGFP. In contrast, SRC2-silenced plants showed enhanced susceptibility to CMV infection compared to the control plants. Our data suggest that the PDLP gene might facilitate infection of CMV, thus being a susceptibility factor, while the SRC2 gene could play a role in resistance to CMV infection in N. benthamiana.

11 February 2022
Verified
Book Chapter
Closed access
GBGajendra Mohan Baldodiya
Gajendra Mohan Baldodiya
RSRichita Saikia
Richita Saikia
RPRicky Raj Paswan
Ricky Raj Paswan
BBBasanta Kumar Borah
Basanta Kumar Borah

1 April 2022
Verified
Book Chapter
Closed access
PDF file
RSRichita Saikia
Richita Saikia
RPRicky Raj Paswan
Ricky Raj Paswan
NFNamrata Farwaha
Namrata Farwaha
BBBasanta Kumar Borah
Basanta Kumar Borah

5 August 2020 in Current Journal of Applied Science and Technology
Verified
Journal Article
Closed access
PDF file
RGRubi Gupta
Rubi Gupta
RPRicky Raj Paswan
Ricky Raj Paswan
RSRichita Saikia
Richita Saikia
BBBasanta Kumar Borah
Basanta Kumar Borah
The Severe Acute Respiratory Syndrome Coronavirus-2, originated in Wuhan, China in late 2019 has created a massive pandemic; the disease manifested by the virus was named as COVID-19 by World Health Organization. It has appeared as an unprecedented threat against the global health scenario, as well as the world socio-economic-political structure. The infection of the plausibly animate-origin virus, per se, is not dangerous; but its extremely contagious and infectious nature is the major challenge it has posed. In human, the viral receptor is angiotensin converting enzyme-2, which is present in the cellular membranes of multiple vital organs. The virus has different longevity in different contaminated surfaces which are the principal modes of its transmission. No immunity has so far been reported against the virus; however, immuno-compromised individuals are more vulnerable. For its diagnosis, mainly reverse transcription-based diagnosis is presently being used; however, serological diagnosis is still not a regular practice due to several reasons. Multiple public as well as private sector organizations are working towards vaccine development; research for antiviral drugs and drug-repurposing is also in progress. Several candidate vaccines and drugs are now in various levels of clinical trials. Here, we summarize the scientific basis of the pandemic; its diagnosis, treatment and efforts towards therapeutic development. These efforts will prove useful against future emerging and re-emerging human and non-human epidemics as well as pandemics.

12 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRichita Saikia
Richita Saikia
RPRicky Raj Paswan
Ricky Raj Paswan
BBBasanta Kumar Borah
Basanta Kumar Borah
Bhut Jolokia ( Capsicum chinense Jacq.) is one of the hottest chillies and an economically important crop in the northeastern regions of India. A major problem in the cultivation of Bhut Jolokia is the occurrence of leaf curl disease, which causes huge annual economic losses. The present study reveals the viral complex associated with the leaf curl disease in Bhut Jolokia collected from different geographical locations in Assam. A novel begomovirus betasatellite component was identified in two Bhut Jolokia samples, which was phylogenetically distinct from known begomovirus betasatellites. DAS-ELISA and PCR analysis confirmed the presence of multiple plant viruses including Chilli leaf curl virus (ChiLCV), Cucumber mosaic virus (CMV), Potato virus Y (PVY) and Tomato leaf curl virus (ToLCV) in most of the naturally infected Bhut Jolokia samples. Phylogenetic analysis revealed that the coat protein ( CP ) gene of ChiLCVs and ToLCVs were highly conserved compared to the CP of CMV.